HER2-Gastric/Gastroesophageal Junction Cancer
1 clinical trials · Condition
◉ Watch HER2-Gastric/Gastroesophageal Junction Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Clinical Study of ABSK061 and ABSK043 (NCT06632262) | Abbisko Therapeutics Co, Ltd | 2024-11-13 |
Track HER2-Gastric/Gastroesophageal Junction Cancer automatically
Every clearance here is in the API, with alerts when new ones post.